Carmen Einmo, 16, suffered a concussion after falling off a horse. A new study shows that incorporating psychological care and coordinated care improves outcomes for adolescents with persistent concussion symptoms.
Concussions can create a host of symptoms—headache, dizziness, moodiness, upset stomach and other issues. In most cases, those symptoms eventually dissipate, but about 15% of young people who get concussions struggle with persistent symptoms despite seeing doctors and receiving medical care. The ongoing symptoms interfere with school, social life and physical activity.
“We were pleased to find that using an approach that adds a psychological care component to treating concussions and providing coordination of care in areas of the patient’s life significantly improved outcomes,” said Dr. Cari McCarty, a psychologist and researcher at Seattle Children’s Research Institute who led the study. “This new approach aims to improve the quality of life for patients who were otherwise left to deal with unrelenting concussion symptoms.” Read full post »
Seattle Children’s Research Institute is celebrating 10 years with a Science Block Party on Saturday Sept. 10 from 11 a.m. to 3 p.m.
As one of the nation’s top five pediatric research centers and one of only 31 centers in the world dedicated to pediatric research, Seattle Children’s Research Institute has made tremendous strides since it opened its doors 10 years ago. From pioneering cystic fibrosis treatments to cutting-edge cancer therapies, our researchers have made their mark in helping to prevent, treat and eliminate childhood disease.
On Saturday, Sept. 10 from 11 a.m. to 3 p.m., the public is invited to a free Science Block Party for kids and adults to celebrate the 10th anniversary of the institute in downtown Seattle. Kids, parents and community members will have the chance to meet researchers and play games that illuminate how medical advancements happen in our labs and clinics.
“The Seattle community has supported us every step of the way as we search for better treatments and new cures for pediatric diseases,” said Dr. Jim Hendricks, president of Seattle Children’s Research Institute. “In celebrating our 10th anniversary in downtown Seattle, we thank the doctors, researchers, families, patients and donors who have helped advance science to improve children’s lives.”
As the institute celebrates 10 years, On the Pulse takes a look at some of the most exciting pediatric innovations and discoveries. Read full post »
Researchers in Seattle and Portland believe web and mobile tools could be used by young people to respond effectively to concerning social media content they see from their peers.
What if a text message could prevent the next violent tragedy, or prevent a despondent teen from dying due to suicide? Two research teams hope that new mobile and web tools could do exactly that.
Distraught young people often turn to social media as an outlet and write posts about having thoughts of self-harm, violence or other concerning issues. The audience for these posts is often a troubled teen’s young peers who are left to grapple with the content and what to do about it.
A new study shows that pregnant women’s exposure to a chemical commonly found in plastic is directly linked to abnormalities in newborn boys’ reproductive organs.
Doctors and researchers know that man-made chemicals commonly found in plastics, foods, personal care products and building materials can interfere with how hormones like estrogen and testosterone work in the body.
A new study published in the journal Environmental Research now shows that pregnant women’s exposure to a particular endocrine-disrupting chemical called diethylhexyl pthalate (DEHP) is directly linked to abnormalities in newborn boys’ reproductive organs.
In this lab stain, the small orange-spotted cell on the far left shows a nerve cell infected with herpes virus in an animal model.
There are a couple strains of herpes so common that researchers estimate 90% of the human population have them. These strains, human herpes 6 and human herpes 7, usually do not cause severe symptoms when people acquire them. But researchers know that under certain circumstances, dormant herpes viruses in the body can unexpectedly come roaring back and cause complications not typically associated with herpes virus.
“It’s common to find herpes virus in salivary glands of humans and animals,” Barcy said. “But we found herpes 7 in the nervous system of animal models, which was a surprise because that strain of herpes has not been detected in the nervous system before. We want to understand what it does in the nervous system, if the virus is also in the human nervous system and if it could be associated with nerve diseases.” Read full post »
Dr. Philippe Coulon thinks electrical signals directly exchanged between brain cells may hold promise as a potential target for absence epilepsy treatments.
A child with absence epilepsy may be in the middle of doing something—she could be dancing, studying, talking—when all of a sudden she stares off into space for a few moments. Then, as quickly as she drifted off, the child snaps back into whatever she was doing, unaware that the episode occurred.
That brief moment of disconnect from reality is called an absence seizure, and according to the Epilepsy Society, childhood absence epilepsy accounts for 2-8% of all epilepsy diagnoses. Most cases of childhood absence epilepsy end after puberty, but about 30% of cases continue into adulthood or lead to other forms of epilepsy, says Dr. Philippe Coulon, a neuroscientist at Seattle Children’s Research Institute.
“Some kids can have hundreds of these brief seizures a day,” said Coulon. “I can only imagine how hard it is for them to function and have a normal childhood.”
In a study published in the Journal of Physiology, Coulon and his colleagues suggest that electrical signals directly exchanged between brain cells may hold promise as a potential target for absence epilepsy treatments. Read full post »
Group B streptococcus (GBS) is the most common life-threatening bacterial infection in newborns worldwide. GBS typically resides in the lower genital tract but does not cause infections in healthy women. But if the infection is transmitted to an infant during pregnancy, it can lead to preterm birth or stillbirth. If the infection is transmitted to a newborn, it can cause pneumonia, sepsis or meningitis, all of which can occur within the first week of life or within 90 days of birth. The goal of my research is to prevent maternal to infant transmission of GBS.
But not all babies become infected. In the U.S. and other developed countries, pregnant women are screened for GBS around the 37th week of gestation. If found positive, a pregnant woman is given antibiotics during labor to prevent the newborn from being infected, and that has reduced transmission of GBS from mothers to infants during birth. However, infections that occur earlier than 37 weeks or after 1 week of birth are not prevented by these measures. Read full post »
This image shows neurons in the newly identified PiCo region of the brain. The researchers used staining techniques to identify the chemical identity of the neurons, which helps give insight into their function.
Neuroscientists at Seattle Children’s Research Institute have discovered an area of the brain that plays a key role in breathing. In a study published in the journal Nature the researchers describe the newly identified area of the brain, which they found plays a key role in exhalation.
“In healthy people, breathing is something we do whether or not we consciously think about it,” said Dr. Nino Ramirez, Director of the Center for Integrative Brain Research at Seattle Children’s Research Institute. “This paper describes a part of the brain that is active during passive exhalation, which is important for swallowing, speaking, coughing, and other behaviors that occur after an inhalation.”
The researchers called this region of the brain the postinspiratory complex, or PiCo. Further study and understanding of how this region of the brain works could lead to the development of new treatments for certain neurodegenerative diseases that involve breathing abnormalities.
This image shows mouse red blood cells infected with Plasmodium parasites, the causative agent of malaria. The cells with the blue ring-like structures inside of them are the malaria parasite-infected red blood cells called Merozoites, which are the blood stage form of the parasite. CREDIT: University of Washington
Dr. David Rawlings knows how painful and devastating malaria is—he had it several times in his early 20s while teaching grade school in Kenya.
“It’s a horrible infection,” said Rawlings, director of the Center for Immunity and Immunotherapies at Seattle Children’s Research Institute. “I had a high fever, severe headaches, chills and I couldn’t leave my house for days. I was fortunate to have medications that stopped the infection, but malaria these days is resistant to most of these drugs.”
Rawlings recovered from the bouts of malaria, but young children who get malaria are not always so lucky. According to the Centers for Disease Control and Prevention, 214 million cases of malaria occurred worldwide in 2015 and resulted in 438,000 deaths, most of them children in Africa. The disease is a parasitic infection spread through the bite of infected mosquitos.
Seeing his young students in Africa come down with malaria is what pushed Rawlings to become an immunologist. He wanted to find a cure.
Tranisha Arzah, 26, was born with HIV and works as an HIV educator.
People who acquire HIV can lose a critical function in their body: their immunity. Left untreated, HIV infects the immune system and disables a person’s ability to fight infections, which can turn the common cold into a death sentence. Antiviral treatment can prevent this from happening, but if medications are stopped the virus comes back almost immediately.
Currently, one out of every 200 American adults lives with HIV. As doctors, scientists and advocates gather in South Africa this week at the International AIDS Conference, researchers at Seattle Children’s have been thinking hard about how to kick HIV, and they have an ambitious goal: They want to develop an immunotherapy that harnesses the power of the immune system to kill and resist HIV.
“Immunotherapy has been successful in treating cancer and we’re optimistic that we can take that same technology and apply it to HIV,” said Dr. Thor Wagner, an infectious disease specialist and pediatrician at Seattle Children’s Research Institute. “The hope is that in the future we’ll be able to take an HIV-positive person’s T cells and re-engineer them to attack and resist the virus.” Read full post »
Seattle Children’s provides healthcare for the special needs of children regardless of race, color, creed, national origin, religion, sex (gender), sexual orientation or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.